tiprankstipranks
Evaxion Biotech (EVAX)
NASDAQ:EVAX
US Market
EVAX
Evaxion Biotech
RESEARCH TOOLSreports

Evaxion Biotech (EVAX) Financial Statements

Compare
402 Followers

Evaxion Biotech Financial Overview

Evaxion Biotech's market cap is currently $29.94M. The company's EPS TTM is $-0.02; its P/E ratio is -3.95; Evaxion Biotech is scheduled to report earnings on March 5, 2026, and the estimated EPS forecast is $-0.01. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Mar 25Dec 23Mar 23Dec 21
Income Statement
Total Revenue$ 7.55M$ 3.34M$ 73.00K$ 0.00$ 0.00
Gross Profit$ 7.53M$ 3.34M$ 73.00K$ 0.00$ 0.00
Operating Income$ -9.26M$ -14.73M$ -22.20M$ -25.26M$ -25.83M
EBITDA$ -8.65M$ -9.79M$ -21.40M$ -22.57M$ -24.21M
Net Income$ -7.73M$ -10.57M$ -22.13M$ -23.17M$ -24.53M
Balance Sheet
Cash & Short-Term Investments$ 23.23M$ 5.05M$ 4.18M$ 13.18M$ 32.17M
Total Assets$ 28.41M$ 12.48M$ 12.89M$ 22.02M$ 40.16M
Total Debt$ 7.50M$ 10.10M$ 10.87M$ 10.26M$ 3.69M
Net Debt$ -15.73M$ 5.05M$ 6.69M$ -2.93M$ -28.48M
Total Liabilities$ 11.37M$ 14.14M$ 17.62M$ 13.72M$ 7.73M
Stockholders' Equity$ 17.04M$ -1.65M$ -4.73M$ 8.30M$ 32.44M
Cash Flow
Free Cash Flow$ -6.66M$ -12.94M$ -17.78M$ -26.07M$ -23.29M
Operating Cash Flow$ -6.65M$ -12.94M$ -17.69M$ -25.77M$ -21.93M
Investing Cash Flow$ -14.04K$ -3.00K$ -93.00K$ -268.00K$ -1.33M
Financing Cash Flow$ 22.48M$ 13.13M$ 10.69M$ 7.85M$ 49.80M
Currency in USD

Evaxion Biotech Earnings and Revenue History

Income Statement >

Evaxion Biotech Debt to Assets

Balance Sheet >

Evaxion Biotech Cash Flow

Cash Flow >

Evaxion Biotech Forecast EPS vs Actual EPS

Earnings >